These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 10530696)

  • 1. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
    Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients.
    Wilson EA; Sills GJ; Forrest G; Brodie MJ
    Epilepsy Res; 1998 Jan; 29(2):161-6. PubMed ID: 9477149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
    Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
    Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A; Treiman DM
    Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
    Leiderman DB
    Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.
    Korn-Merker E; Borusiak P; Boenigk HE
    Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
    Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
    Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind study of Gabapentin in the treatment of partial seizures.
    Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P
    Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E
    Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin.
    McLean MJ
    Epilepsia; 1995; 36 Suppl 2():S73-86. PubMed ID: 8784216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study.
    Mayer T; Schütte W; Wolf P; Elger CE
    Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin in refractory partial epilepsy--a trial in India.
    Dixit SN; Jain S; Padma MV; Maheshwari MC
    Acta Neurol Scand; 1996; 93(2-3):85-7. PubMed ID: 8741123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.